| Literature DB >> 33596636 |
Ahmad Fariz Malvi Zamzam Zein1, Rabbinu Rangga Pribadi2, Uswatun Khasanah3, Muhammad Begawan Bestari4, Ari Fahrial Syam2.
Abstract
BACKGROUND/AIMS: The coronavirus disease 2019 (COVID-19) pandemic has necessitated modifications to allow the safe practice of clinical gastroenterology and gastrointestinal endoscopy. This study aimed to investigate the characteristics of clinical gastroenterology and gastrointestinal endoscopy practices during the COVID-19 pandemic in Indonesia.Entities:
Keywords: COVID-19; Clinical; Gastroenterology; Gastrointestinal endoscopy; Practice
Year: 2021 PMID: 33596636 PMCID: PMC8182243 DOI: 10.5946/ce.2020.216
Source DB: PubMed Journal: Clin Endosc ISSN: 2234-2400
Distribution of Participants Based on Indonesian Society for Digestive Endoscopy Branches
| No. | ISDE regional branch | Participants per branch ( | Total members per branch ( |
|---|---|---|---|
| 1 | Papua | 2 | 2 |
| 2 | Maluku | 1 | 1 |
| 3 | Mataram | 2 | 8 |
| 4 | Manado | 2 | 9 |
| 5 | Makassar | 2 | 18 |
| 6 | Denpasar | 7 | 21 |
| 7 | Samarinda | 5 | 11 |
| 8 | Banjarmasin | 5 | 6 |
| 9 | Kalimantan Barat | 2 | 7 |
| 10 | Surabaya | 21 | 70 |
| 11 | Malang | 5 | 12 |
| 12 | Surakarta | 5 | 25 |
| 13 | Semarang | 8 | 32 |
| 14 | Yogyakarta | 9 | 28 |
| 15 | Bandung | 32 | 37 |
| 16 | Jakarta | 53 | 159 |
| 17 | Lampung | 3 | 8 |
| 18 | Padang | 5 | 13 |
| 19 | Pekanbaru | 11 | 23 |
| 20 | Palembang | 6 | 24 |
| 21 | Medan | 9 | 40 |
| 22 | Banda Aceh | 5 | 15 |
| Total | 200 | 569 |
ISDE, Indonesian Society for Digestive Endoscopy.
Baseline Characteristic of the Participants
| Characteristics | Frequency ( | Percent (%) | |
|---|---|---|---|
| Age, yr | • <60 | 171 | 85.5 |
| • >60 | 29 | 14.5 | |
| Sex | • Male | 148 | 74.0 |
| • Female | 52 | 26.0 | |
| Competence | • Consultant of gastroenterology and hepatology | 59 | 29.5 |
| • Fellow of gastroenterology and hepatology | 15 | 7.5 | |
| • Fellow of pediatric gastroenterology | 1 | 0.5 | |
| • Internal medicine specialist with competence in basic GIE | 125 | 62.5 | |
| Work experience, yr | • <5 | 65 | 32.5 |
| • 5–10 | 69 | 34.5 | |
| • >10 | 66 | 33.0 | |
| Learning source | • ISDE/ISG/InaASL | 195 | 97.5 |
| • APAGE | 5 | 2.5 | |
| • ASGE | 2 | 1.0 | |
| • ESGE | 2 | 1.0 | |
| Workplace | • Government teaching hospital | 68 | 34.0 |
| • Government non-teaching hospital | 41 | 20.5 | |
| • Private teaching hospital | 10 | 5.0 | |
| • Private non-teaching hospital | 79 | 39.5 | |
| • Others | 2 | 1.0 |
APAGE, Asian Pacific Association of Gastroenterology; ASGE, American Society for Gastrointestinal Endoscopy; ESGE, European Society of Gastrointestinal Endoscopy; GIE, gastrointestinal endoscopy; InaASL, Indonesian Association for the Study of the Liver; ISDE, Indonesian Society for Digestive Endoscopy; ISG, Indonesian Society of Gastroenterology.
Modifications to Clinical Gastroenterology Practice during the Study
| Patterns of clinical gastroenterology practice | Frequency ( | Percent (%) | |
|---|---|---|---|
| Outpatient setting | • Reduction of consultation duration | 88 | 44.0 |
| • Reduction of working hours | 140 | 70.0 | |
| • Reduction of the number of attended patients | 127 | 63.5 | |
| • Restriction of the workplace | 32 | 16.0 | |
| • Cessation of face-to-face consultation | 18 | 9.0 | |
| • Utilization of teleconsultation via | 32 | 16.0 | |
| • Utilization of teleconsultation via a hospital-recommended application | 48 | 24.0 | |
| • No modification | 9 | 4.5 | |
| Inpatient setting | • Limitation of visit duration | 94 | 47.0 |
| • Reduction of working days | 45 | 22.5 | |
| • Limitation of the number of hospitalized patients | 68 | 34.0 | |
| • Limitation of the workplace | 22 | 11.0 | |
| • Cessation of visits | 15 | 7.5 | |
| • Utilization of teleconsultation via | 12 | 6.0 | |
| • Utilization of teleconsultation via a hospital-recommended application | 17 | 8.5 | |
| • No modification | 0 | 0 | |
| Difficulty in performing clinical research | • Yes | 141 | 70.5 |
| • No | 59 | 29.5 | |
SMS, short message service.
Modifications to Gastrointestinal Endoscopy Practice during the Study
| Patterns of GIE practice | Frequency ( | Percent (%) | |
|---|---|---|---|
| Changes in GIE practice patterns | • Limitation of GIE duration | 13 | 6.5 |
| • Reduction of working days | 26 | 13.0 | |
| • Limitation of the number of attended patients | 71 | 35.5 | |
| • Partial cessation of elective GIE | 47 | 23.5 | |
| • Cessation of all GIE | 113 | 56.5 | |
| • No modification | 0 | 0 | |
| Indications of GIE during the study | • Gastrointestinal symptom(s) without alarm sign(s) | 11 | 5.5 |
| • Gastrointestinal symptom(s) with alarm sign(s) | 121 | 60.5 | |
| • Upper gastrointestinal obstruction | 49 | 24.5 | |
| • Lower gastrointestinal obstruction | 44 | 22.0 | |
| • Screening for colorectal cancer | 20 | 10.0 | |
| • Cancer staging | 3 | 1.5 | |
| • Polypectomy | 7 | 3.5 | |
| • Screening for hepatocellular carcinoma or liver cirrhosis | 45 | 22.5 | |
| • Hematemesis and/or melena | 147 | 73.5 | |
| • Hematochezia | 115 | 57.5 | |
| • Obstructive jaundice | 25 | 12.5 | |
| PPE during upper GIE | • Face shield | 195 | 97.5 |
| • Head cap | 162 | 81.0 | |
| • Goggles | 129 | 64.5 | |
| • N95 mask | 140 | 70.0 | |
| • Surgical mask | 115 | 57.5 | |
| • Coveralls | 96 | 48.0 | |
| • Surgical gown | 112 | 56.0 | |
| • Double gloves | 137 | 68.5 | |
| • Single glove | 45 | 22.5 | |
| • Boot | 164 | 82.0 | |
| • Shoe cover | 67 | 33.5 | |
| PPE during lower GIE | • Face shield | 178 | 89.0 |
| • Head cap | 158 | 79.0 | |
| • Goggles | 115 | 57.5 | |
| • N95 mask | 104 | 52.0 | |
| • Surgical mask | 91 | 45.5 | |
| • Coveralls | 66 | 33.0 | |
| • Surgical gown | 82 | 41.0 | |
| • Double gloves | 104 | 52.0 | |
| • Single glove | 23 | 11.5 | |
| • Boot | 85 | 42.5 | |
| • Shoe cover | 44 | 22.0 | |
| Modification in GIE unit staff | • Yes | 28 | 14.0 |
| • No | 172 | 86.0 | |
GIE, gastrointestinal endoscopy; PPE, protective personal equipment.
Physician Risk Identification
| Risk identification | Frequency ( | Percent (%) | |
|---|---|---|---|
| Risk identification according to symptom(s) | • Yes | 3 | 1.5 |
| • No | 197 | 98.5 | |
| Risk identification according to contact history | • Yes | 15 | 7.5 |
| • No | 185 | 92.5 | |
| Risk identification according to travel history | • Yes | 43 | 21.5 |
| • No | 157 | 78.5 | |
| Risk identification according to exposure to high-risk zones | • Yes | 172 | 86.0 |
| • No | 28 | 14.0 | |
| Self-detection with antibody-based testing | • Yes | 127 | 63.5 |
| • No | 73 | 36.5 | |
| Self-detection with RT-PCR-based testing | • Yes | 59 | 29.5 |
| • No | 141 | 70.5 | |
| Availability of adequate PPE | • Yes | 132 | 66.0 |
| • No | 68 | 34.0 | |
| Performing GIE on suspected/confirmed COVID-19 patients | • Yes | 15 | 7.5 |
| • No | 185 | 92.5 |
COVID-19, coronavirus disease 2019; GIE, gastrointestinal endoscopy; PPE, protective personal equipment; RT-PCR, reverse transcriptase polymerase chain reaction.
Participants’ Involvement in the Management of Coronavirus Disease 2019
| Type of involvement | Frequency ( | Percent (%) | |
|---|---|---|---|
| COVID-19 physician team | • Yes | 137 | 68.5 |
| • No | 63 | 31.5 | |
| COVID-19 task force | • Yes (taskforce at a hospital) | 107 | 53.5 |
| • Yes (task force in a professional organization) | 90 | 45.0 | |
| • Yes (government task force) | 3 | 1.5 | |
| • No | 4 | 2.0 |
COVID-19, coronavirus disease 2019.